Alys Pharmaceuticals has received clearance from the US FDA and Health Canada for a Phase IIa trial of ALY-101 for alopaecia ...

The Washington University trial comes as part of a larger platform study which hopes to understand if Alzheimer's disease can ...

The first-in-human SCS trial saw all three SMA patients able to increase their walking distance within six minutes to 20 meters.

Cumberland Pharmaceuticals has reported positive outcomes from a trial of ifetroban as a potential treatment for Duchenne ...

The Phase II trial will test the combination of opaganib and darolutamide in male mCRPC patients with poor prognosis. Credit: Chinnapong / Shutterstock. Israeli pharmaceutical company RedHill ...